Travere Therapeutics (TVTX) PT Raised to $62 at Citi Jun 3, 2026 12:53PM
Citi Adjusts Catalyst Call List Mar 24, 2026 05:03AM
Travere Therapeutics (TVTX) PT Raised to $48 at Citi, New Catalyst Watch Oct 31, 2025 09:04AM
Travere Therapeutics to Participate at Upcoming Investor Conferences Aug 5, 2025 04:30PM
Travere Therapeutics (TVTX) PT Lowered to $32 at Citi, Adds 90d Upside Catalyst Watch Jun 11, 2025 04:58AM


May 16, 2025 04:20AM Citi on Travere Therapeutics (TVTX): 'we would buy the dip', Opens 30-Day Upside Catalyst Call
Feb 24, 2025 04:58AM Travere Therapeutics (TVTX) PT Raised to $35 at Citi
Nov 25, 2024 04:30PM Travere Therapeutics to Present at Upcoming Investor Conferences
Sep 27, 2024 07:23AM Travere Therapeutics (TVTX) PT Lowered to $19 at Citi
Sep 6, 2024 09:49AM Travere Therapeutics (TVTX) PT Raised to $23 at Citi, 'Full Approval as Expected and We Expect Positive Inflection in Sales Trajectory'
Dec 5, 2023 06:55AM Citi Upgrades Travere Therapeutics (TVTX) to Buy
Nov 20, 2023 05:09AM Citi Starts Travere Therapeutics (TVTX) at Neutral